Pfizer vax linked to woman’s blood clots: overseas case
The 59-year-old Omani woman developed thromboembolism that was thought to be heparin-induced thrombocytopenia within days of her first dose, with no other risk factors identified, say her doctors
Doctors have highlighted a possible link between the Pfizer-BioNTech COVID-19 vaccine and blood clots, after a woman developed what was thought to be heparin-induced thrombocytopenia (HIT) after her first dose.
The 59-year-old presented to the ED with a three-day history of sudden-onset leg pain one week after she was vaccinated, report doctors from Sultan Qaboos University Hospital in Muscat, Oman.
